beta
집행유예
(영문) 서울남부지방법원 2012.9.20.선고 2012고단2538 판결

약사법위반

Cases

2012 Highest 2538 Violation of the Pharmaceutical Affairs Act

Defendant

유ㅇㅇ ( 70 - 1 ), ㅇㅇ

Seoul Housing Jongno-gu Seoul

Reference domicile Jincheon-gun District

Prosecutor

Subscopic (prosecutions), B. B. (Public Trial)

Defense Counsel

Law Firm Squa

Attorney Jeong Young-hoon, and Kim Dong-dong

Imposition of Judgment

September 20, 2012

Text

A defendant shall be punished by imprisonment for one year.

However, the execution of the above punishment shall be suspended for two years from the date of the final judgment.

Reasons

Criminal History Office

피고인은 의약품의 품목허가를 받아 의약품을 제조 · 판매하는 주식회사 ㅇㅇ제약의 대표이사로 의약품 판매 포함 회사 업무 전반을 총괄하는 사람이다 .

A person who has obtained marketing approval of drugs shall not provide money, goods, benefits, labor, entertainment, or other economic benefits to medical personnel, founders of medical institutions, or employees of medical institutions for the purpose of sales promotion, such as adoption of drugs and guidance for prescription.

피고인은 2011. 1. 경 서울 영등포구 ㅇㅇ 동 000 - 0 에 있는 권ㅇㅇ 운영의 ' ㅇㅇ정 형외과의원 ' 에서, 위 ㅇㅇ 제약의 영업사원을 통하여 원장 권ㅇㅇ에게 위 ㅇㅇ 제약이 제조 · 판매하는 의약품인 ' ㅇㅇㅇ 캡슐 ' 등의 판매촉진 및 처방유도 등을 목적으로 위 의약품들에 대한 향후 1년간의 예상 처방액 대비 15 % 에 해당하는 금액을 일명 ' 선지원 금 ' 명목으로 제공하기로 약속하고, 이에 따라 2011. 1. 31. 경 1, 200만 원을 위 권ㅇ이

The transfer was made to the nominal account.

이를 비롯하여 피고인은 2010. 12. 경부터 2011. 7. 경까지 사이에 별지 범죄일람표 기재와 같이 전국 321곳의 병 · 의원 개설자 및 소속 의사들에게 ㅇㅇ 제약이 제조 · 판매하는 의약품인 ' ㅇㅇㅇㅇ 캅셀 ' 등 11개 품목의 판매촉진 및 처방유도 등을 목적으로 향후 1년간의 예상 처방액 대비 10 ~ 15 % 에 해당하는 금액을 일명 ' 선지원금 ' 명목으로 지급하기로 하고 442회에 걸쳐 의사 및 그 지인들 명의 계좌로 합계 1, 667, 820, 000원을 송금하여 금원을 지급하였다 .

Summary of Evidence

1. Defendant's legal statement;

1. 피고인, 이ㅇㅇ, 박ㅇㅇ, 윤ㅇㅇ에 대한 각 검찰피의자신문조서 ( 사본 )

1. 서ㅇㅇ에 대한 검찰진술조서

1. A copy of an accusation, a copy of remittance sources' details, personal information of a business assistant manager, the current status of monthly interest processing, the arrangement of the details of payment of allowances for the book-keeping, the current status of sales by each hospital, the current status of sales by each hospital, and the payment of each

1. Each investigation report;

Application of Statutes

1. Article relevant to the facts constituting an offense and the selection of punishment;

Where economic benefits are paid several times to the same provider, each of them shall be covered by each provider, and Articles 94-2 and 47(2) of the Pharmaceutical Affairs Act (Selection of Imprisonment);

1. Aggravation for concurrent crimes;

Articles 37 (former part), 38 (1) 2, and 50 of the Criminal Act

1. Suspension of execution;

Article 62(1) of the Criminal Act (see, e.g., Reasons for Sentencing)

The reason for sentencing argues that rebates practices existing in the medical sector for sentencing distort the sound distribution system and the sales order of the pharmaceutical, and ultimately, it may infringe on the citizens' health health rights. The adoption of the pharmaceutical is highly likely to be criticized, and that the funds provided to medical personnel, etc. in return for the adoption of the pharmaceutical do not amount to 1.6 billion won in a short period, and the Defendant has formed rebates practices for a long time to live in the pharmaceutical company due to the high competition in sales of the same kind of product. However, this is ultimately unfavorable to the Defendant, such as the fact that it is impossible to justify the practices of rebates for the economic benefit of the pharmaceutical company, by providing the medical personnel and the founders of medical institutions for the purpose of promoting the sale of medicines. However, the Defendant voluntarily cooperates with the prosecutor's investigation of the instant crime and submitted important investigation data, such as the details of rebates, etc., the Defendant has no particular criminal record, the Defendant has been detained for a considerable period of time, and the Defendant has no favorable means and conditions of the Defendant's family relationship after the aforementioned crime.

Judges

Judges Jeon Soo-tae